The local injection of CAR-T cells also increases the CD8+ T cells in the tumor because the systemic injection restricts the transport of CD8+ T cells in the blood circulation as it indicated by the slight decrease of CD8+ T cells at the time of CAR-T cell injection in both Control and anti-VEGF (see number of CD8+ T cells in Fig. 8). Here, CD8A is linked to neoplasm.